FDA Approved: YUTREPIA — Original Application (Liquidia Technologies, Inc.)

View source ↗

Summary

FDA approved YUTREPIA (treprostinil) from Liquidia Technologies as an original application for the treatment of pulmonary arterial hypertension to improve exerc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• YUTREPIA (treprostinil)

Snippet

ORIG AP for YUTREPIA (TREPROSTINIL)